Edward Shelton

857 total citations
19 papers, 502 citations indexed

About

Edward Shelton is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Edward Shelton has authored 19 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Edward Shelton's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Edward Shelton is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Edward Shelton collaborates with scholars based in Australia, United States and France. Edward Shelton's co-authors include Ashwin N. Ananthakrishnan, Vijay Yajnik, James D. Lewis, Ronac Mamtani, Jean‐Frédéric Colombel, Frank I. Scott, David Laharie, Deanna D. Nguyen, Hamed Khalili and Jenny Sauk and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and Gastrointestinal Endoscopy.

In The Last Decade

Edward Shelton

18 papers receiving 496 citations

Peers

Edward Shelton

EPIDE

GENET

SURGE

IMMUN

PHEOH

Paula Ministro Portugal

Frank Czul United States

Atsushi Yoden Japan

Abhinav Vasudevan Australia

Christian Primas Austria

Annalisa Aratari Italy

Sadie M. Marden United Kingdom

J. Chao United States

Aurelio Lorenzo Spain

Alberto Prada Italy

Paula Ministro Portugal

Edward Shelton

333 ×1.1

EPIDE

420 ×1.5

GENET

224 ×1.6

SURGE

93 ×0.8

IMMUN

45 ×0.7

PHEOH

Citations per year, relative to Edward Shelton Edward Shelton (= 1×) peers Paula Ministro

Countries citing papers authored by Edward Shelton

Since Specialization

Citations

This map shows the geographic impact of Edward Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Shelton more than expected).

Fields of papers citing papers by Edward Shelton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Shelton. The network helps show where Edward Shelton may publish in the future.

Co-authorship network of co-authors of Edward Shelton

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Shelton. A scholar is included among the top collaborators of Edward Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Shelton. Edward Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Chang, Yu‐Mei, et al.. (2025). Progression of Chronic Kidney Disease in Cats After Subcutaneous Ureteral Bypass Placement Compared to Cats With Idiopathic Chronic Kidney Disease. Journal of Veterinary Internal Medicine. 39(5). e70242–e70242.

Shelton, Edward, et al.. (2024). Feasibility of transperineal intestinal ultrasound in assessing ulcerative proctitis during pregnancy. JGH Open. 8(11). e70035–e70035. 1 indexed citations

Shelton, Edward, et al.. (2022). Impact of a pharmacist‐led thiopurine monitoring service in outpatients with inflammatory bowel disease. Internal Medicine Journal. 53(5). 779–786. 2 indexed citations

Wright, Emily K., Bronte A. Holt, Tom Sutherland, et al.. (2021). P300 Crohn’s Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT Randomised Controlled Trial. Journal of Crohn s and Colitis. 15(Supplement_1). S328–S330. 2 indexed citations

Wright, Emily K., Bronte A. Holt, Amy L. Hamilton, et al.. (2021). Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial. The Lancet. Gastroenterology & hepatology. 7(4). 318–331. 37 indexed citations

Wright, Emily K., Bronte A. Holt, Tom Sutherland, et al.. (2021). 459 CROHN'S DISEASE STRICTURES RESPOND TO DRUG TREATMENT AND TREAT-TO-TARGET INTENSE COMBINATION THERAPY IS MORE EFFECTIVE THAN STANDARD ANTI-TNF THERAPY. THE STRIDENT RANDOMISED CONTROLLED TRIAL.. Gastroenterology. 160(6). S–92. 1 indexed citations

Flanagan, Emma, Emily K. Wright, Miles Sparrow, et al.. (2021). A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflammatory Bowel Diseases. 27(12). 1909–1918. 13 indexed citations

Zanden, Esmerij P. van der, Emma Flanagan, Sally Bell, et al.. (2019). Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis. Journal of Crohn s and Colitis. 13(12). 1527–1536. 2 indexed citations

Holt, Darcy, Michael P. Swan, Edward Shelton, et al.. (2018). Immunomodulator use does not prevent first loss of response to anti‐tumour necrosis factor alpha therapy in inflammatory bowel disease: long‐term outcomes in a real‐world cohort. Internal Medicine Journal. 49(6). 753–760. 5 indexed citations

10.

Shelton, Edward, David Laharie, Frank I. Scott, et al.. (2016). Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Gastroenterology. 151(1). 97–109.e4. 106 indexed citations

11.

Kochar, Bharati, Millie D. Long, Edward Shelton, et al.. (2016). Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn’s Disease and Need for Parenteral Support Due to Short Bowel Syndrome–associated Intestinal Failure. Journal of Clinical Gastroenterology. 51(6). 508–511. 46 indexed citations

12.

Shelton, Edward, Jessica R. Allegretti, Betsy W. Stevens, et al.. (2015). Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients. Inflammatory Bowel Diseases. 21(12). 2879–2885. 137 indexed citations

13.

Stevens, Betsy W., Edward Shelton, Hamed Khalili, et al.. (2015). Tu1359 Efficacy of Vedolizumab As Induction Therapy in Refractory IBD Patients Following Multiple Anti-TNF Therapy Failures. Gastroenterology. 148(4). S–869. 2 indexed citations

14.

Shelton, Edward, Khadija Chaudrey, Jenny Sauk, et al.. (2015). New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 41(10). 972–979. 51 indexed citations

15.

Lontos, Steve, Edward Shelton, Peter Angus, et al.. (2014). A randomized controlled study of trimethoprim‐sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients. Journal of Digestive Diseases. 15(5). 260–267. 25 indexed citations

16.

Chandran, Sujievvan, Adam Testro, Edward Shelton, et al.. (2013). Risk stratification of upper GI bleeding with an esophageal capsule. Gastrointestinal Endoscopy. 77(6). 891–898. 12 indexed citations

17.

Trevillyan, Janine M., Peter Angus, Edward Shelton, et al.. (2013). Electronic Estimations of Renal Function Are Inaccurate in Solid-Organ Transplant Recipients and Can Result in Significant Underdosing of Prophylactic Valganciclovir. Antimicrobial Agents and Chemotherapy. 57(8). 4058–4060. 15 indexed citations

18.

Shelton, Edward, Paul R. Froomes, & Michael Fink. (2012). Gastrointestinal: Balloon pancreatitis. Journal of Gastroenterology and Hepatology. 27(5). 986–986. 5 indexed citations

19.

Shelton, Edward, Michelle K. Yong, & S. Cohney. (2009). Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection. Nephrology. 14(7). 696–699. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact